STAT
DECEMBER 17, 2024
Namandjé Bumpus, principal deputy commissioner of the Food and Drug Administration, is leaving the agency. Commissioner Robert Califf shared the news with staff Tuesday morning, according to an email reviewed by STAT.
PharmaVoice
DECEMBER 17, 2024
Rising maternal mortality, particularly among vulnerable populations, stems in part from a lack of research in pregnant women.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
DECEMBER 17, 2024
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. Congress nears spending deal with long-awaited PBM reforms Congress is on the edge of a deal that would reshape pharmacy benefit managers, extend telehealth access, and renew certain public health authorities.
PharmaVoice
DECEMBER 17, 2024
Bluejay Therapeutics is one of just a handful of companies developing treatments for hepatitis D.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The Pharmacist
DECEMBER 17, 2024
Around half of adults in the UK struggle to access trusted health information, according to a new report. The study, published by the Patient Information Forum (PIF) and Ipsos,called Knowledge is Power, found that 53% of people felt they could trust the health information they found offline, with 45% saying they could trust the information […] The post Half of adults struggle to access trusted health information appeared first on The Pharmacist.
BioPharma Dive
DECEMBER 17, 2024
Phase 2 results in inflammatory bowel disease hinted the therapy could be more potent than similar medicines from Merck and Roche, each of which were acquired in multibillion-dollar deals.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Express Pharma
DECEMBER 17, 2024
Revolutionising pharma the adaptive way Pharmaceutical manufacturing is undergoing a transformative development, driven by innovative technologies that enable right-first time (RFT) production and adaptive scaling to meet changing demands. By embracing smart manufacturing, the industry is addressing numerous challenges, allowing consumers to receive life-saving drugs more quickly and sustainably.
The Pharmacist
DECEMBER 17, 2024
Just 58% of trainee pharmacists passed the General Pharmaceutical Council (GPhC)'s national registration assessment this November, the regulator has announced. This brings the pass rates back down almost to November 2022 levels of 56%, following a 10% rise to 66% in November 2023. And it comes as summer pass rates have seen a steady decline […] The post GPhC November pass rate drops again to 2022 levels appeared first on The Pharmacist.
Pharma Times
DECEMBER 17, 2024
New CT-guided radiotherapy system offers personalised cancer treatment
BioPharma Dive
DECEMBER 17, 2024
An FDA approval of Merck’s drug clesrovimab by June would give physicians another option for protecting newborns from respiratory syncytial virus.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Pharma Times
DECEMBER 17, 2024
First patient dosed in landmark trial for GAD treatment
Pharmaceutical Technology
DECEMBER 17, 2024
Construction has already begun on the Ozempic-producers new Denmark production facility and 40,000m2 warehouse.
Express Pharma
DECEMBER 17, 2024
India’s pharmaceutical industry, a global leader in generics, is poised for exponential growth. The sector is targeting a remarkable $130 billion by 2030 and a visionary $450 billion by 2047. Several key trends are shaping the industrys trajectory: Market consolidation: Strategic mergers and acquisitions, primarily backed by private equity, are reshaping the industry landscape.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Pharmaceutical Technology
DECEMBER 17, 2024
The two-day event included talks on subjects ranging from how to best utilise AI to how to build a stable CRO.
Express Pharma
DECEMBER 17, 2024
The schizophrenia market across the seven major markets (7MM*) is poised to grow at a compound annual growth rate (CAGR) of 7.4 per cent from $8.4 billion in 2021 to $17.0 billion in 2031, driven by the anticipated introduction of 11 late-stage pipeline products during the forecast period, according to GlobalData. GlobalDatas latest report, Schizophrenia: Seven-Market Drug Forecast and Market Analysis Update, reveals that the late-stage pipeline products are expected to capture a significant po
BioPharma Dive
DECEMBER 17, 2024
Bumpus replaced agency veteran Janet Woodcock as principal deputy commissioner in February 2024. She was previously the FDA’s chief scientist.
Pharmaceutical Technology
DECEMBER 17, 2024
China National Medical Products Administration (NMPA) has approved MSDs KEYTRUDA for treating certain non-small cell lung cancer (NSCLC).
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
BioPharma Dive
DECEMBER 17, 2024
The company forecast revenue next year will grow slightly versus this year, when excluding certain factors. “The uncertainty caused by COVID [is] mostly resolved,” its CFO said.
Pharmaceutical Technology
DECEMBER 17, 2024
However, caution persists:166 of 785 US venture-backed companies with an innovator drug in development have not raised capital since 2021.
pharmaphorum
DECEMBER 17, 2024
Phase 2b results with Sanofi and Teva's duvakitug are exciting and warrant a swift move to phase 3 in inflammatory bowel disease, say the companies.
Pharmaceutical Technology
DECEMBER 17, 2024
GSKs GSK227 has gained Priority Medicines (PRIME) designation from the EMA for the treatment of relapsed ES-SCLC.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Express Pharma
DECEMBER 17, 2024
Granules India, through its wholly-owned foreign subsidiary Granules Pharmaceuticals (GPI), has received approval from the U.S. Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) for Lisdexamfetamine Dimesylate Chewable Tablets. The product, available in strengths of 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, and 60 mg, is bioequivalent to Vyvanse Chewable Tablets by Takeda Pharmaceuticals USA.
Pharmaceutical Technology
DECEMBER 17, 2024
Bavarian Nordic has signed a licence and manufacturing agreement with the Serum Institute of India (SII) for its mpox vaccine, MVA-BN.
Outsourcing Pharma
DECEMBER 17, 2024
AbbVie acquires Nimble Therapeutics in $200M deal to advance oral peptide therapies for autoimmune diseases.
Drug Patent Watch
DECEMBER 17, 2024
Flexibility has become more than just a buzzword it’s a necessity. Contract Development and Manufacturing Organizations (CDMOs) are at the forefront of this shift, playing a crucial role in bringing innovative therapies to market. But what exactly makes flexibility so important for CDMOs, and how can they cultivate this essential trait? Let’s dive into the world of pharmaceutical outsourcing and explore why adaptability is the key to success.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
pharmaphorum
DECEMBER 17, 2024
Closed Loop Medicine's smartphone app for blood pressure monitoring has shown proof-of-concept in the Cure-19 study.
BioPharma Dive
DECEMBER 17, 2024
Rising maternal mortality, particularly among vulnerable groups, has roots in insufficient research involving pregnant women.
PioneerRx
DECEMBER 17, 2024
In todays day and age, its essential to have modern and adaptable pharmacy technology. Your pharmacy software plays an integral role in its success.
PharmExec
DECEMBER 17, 2024
Margaret Keegan, the new CEO of Precision Medicine Group, is eager to elevate the profile of the expert-rich service provider and build it into an industry leader in next-gen drug development and commercialization support.
Pharmaceutical Commerce
DECEMBER 17, 2024
Cheryl Allen, BS Pharm, MBA, founding partner, Curatio Scientia Advisors, discusses "Enhancing Patient Access and Support Through Technology: A Comprehensive Assessment," and upcoming industry challenges.
Expert insights. Personalized for you.
239 
Let's personalize your content